Mitchell R. Smith

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.9K citations · Full text

Medicine, Hematology, Oncology +16

A bacterial invasin induces macrophage apoptosis by binding directly to ICE.

Yu Chen, Mitchell R. Smith, K Thirumalai et al. · The EMBO Journal · 1996 · 416 citations · Full text

Life Sciences, Immunology, Microbiology +10

Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.

Mitchell R. Smith, Warner C. Greene · Genes & Development · 1990 · 390 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies

Gaurav S. Choudhary, Sayer Al-harbi, Suparna Mazumder et al. · Cell Death and Disease · 2015 · 378 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

Anjali S. Advani, Bertrand Coiffier, Myron S. Czuczman et al. · Journal of Clinical Oncology · 2010 · 334 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17